Comparison of everolimus-eluting bioresorbable vascular scaffolds and metallic stents: three-year clinical outcomes from the ABSORB China randomised trial

Bo Xu1, MBBS; Yuejin Yang1, MD, PhD; Yaling Han2, MD, PhD; Yong Huo3, MD; Lefeng Wang4, MD; Xiangqian Qi5, MD; Jifu Li6, MD; Yundai Chen7, MD; Hai-Chien Kuo8, PhD; Shih-Wa Ying8, MS; Wai-Fung Cheong8, PhD; Yunlong Zhang8, MD; Xiaolu Su8, MS; Jeffery J. Popma9, MD; Runlin Gao1*, MD; Gregg W. Stone10, MD; on behalf of the ABSORB China Investigators